Vylor (NYSE:VYLR) Raised to Strong-Buy at UBS Group

Vylor (NYSE:VYLR) was upgraded by UBS Group to a “strong-buy” rating in a research report issued to clients and investors on Monday, Zacks reports.

A number of other research firms have also commented on VYLR. Royal Bank Of Canada began coverage on shares of Vylor in a research report on Friday, October 2nd. They set an “outperform” rating and a $85.00 price target on the stock. KeyCorp began coverage on shares of Vylor in a report on Wednesday, October 7th. They issued a “sector weight” rating and a $78.00 price objective for the company. BNP Paribas Exane started coverage on shares of Vylor in a research report on Wednesday. They set a “neutral” rating on the stock. Wolfe Research upgraded shares of Vylor to a “strong-buy” rating in a research report on Thursday, October 1st. Finally, The Goldman Sachs Group initiated coverage on shares of Vylor in a report on Thursday, October 8th. They set a “buy” rating and a $87.00 target price on the stock. Three equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $83.36.

Vylor Stock Up 0.9%

VYLR opened at $76.59 on Monday. Vylor has a fifty-two week low of $65.00 and a fifty-two week high of $77.39.

About Vylor

Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.